Integrating Palliative Care for Patients With Idiopathic Pulmonary Fibrosis and Their Caregivers
2 other identifiers
interventional
140
1 country
1
Brief Summary
Patients with Idiopathic Pulmonary Fibrosis (IPF) and their caregivers will be randomized to receive this intervention or usual care. The intervention will include information about the disease, self-management strategies, and introduction to advanced care planning in a format with enhanced content available across multiple domains (face-to-face, printed material, digital (tablet) delivered by an interventionist. The usual care group will be provided with routine printed patient education. At the end of life, IPF patients and their caregivers experience stress, symptom burden, poor quality of life, and inadequate preparedness for end-of-life care planning. The proposed study will measure feasibility, acceptability, and impact of a Supportive Care intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 6, 2016
CompletedFirst Posted
Study publicly available on registry
October 10, 2016
CompletedStudy Start
First participant enrolled
March 23, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 24, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 24, 2020
CompletedAugust 7, 2020
August 1, 2020
3.3 years
October 6, 2016
August 6, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Stress
Perceived Stress Scale at baseline and completion of study in patients and caregivers
3 years
Secondary Outcomes (6)
Disease Preparedness
3 years
Knowledge
3 years
Advance Care Planning
3 years
Quality of Dying and Death
3 years
Symptom Burden
3 years
- +1 more secondary outcomes
Study Arms (2)
Intervention
OTHERGroup will receive SUPPORT, an intervention that provides information about the disease, self-management strategies, and introduction to advanced care planning in a format with enhanced content available across multiple domains (face-to-face, printed material, and digitally (via use of a tablet) delivered by an interventionist.
Usual Care
OTHERGroup will receive usual standard-of-care, and be provided with currently available printed material for information about their illness.
Interventions
Members of this group will receive personal, enhanced printed materials, as well as face-to-face support, and digital information provided by the interventionist.
Subjects will receive their usual standard of care, including currently available printed patient material.
Eligibility Criteria
You may qualify if:
- years or older
- Primary Diagnosis of with Idiopathic Pulmonary Fibrosis (IPF)
- Has a caregiver, 18 years or older (spouse/partner/child/family member/friend), willing to participate.
- Sees a Simmons Center Physician for usual IPF care.
You may not qualify if:
- less than 45 years
- Not diagnosed with IPF
- Has an unwilling caregiver, or a caregiver under 18.
- Does not see a Simmons Center Physician for usual IPF care.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease
Pittsburgh, Pennsylvania, 15213, United States
Related Publications (2)
Lindell KO, Klein SJ, Veatch MS, Gibson KF, Kass DJ, Nouraie M, Rosenzweig MQ. Nurse-Led Palliative Care Clinical Trial Improves Knowledge and Preparedness in Caregivers of Patients with Idiopathic Pulmonary Fibrosis. Ann Am Thorac Soc. 2021 Nov;18(11):1811-1821. doi: 10.1513/AnnalsATS.202012-1494OC.
PMID: 34003726DERIVEDLindell KO, Nouraie M, Klesen MJ, Klein S, Gibson KF, Kass DJ, Rosenzweig MQ. Randomised clinical trial of an early palliative care intervention (SUPPORT) for patients with idiopathic pulmonary fibrosis (IPF) and their caregivers: protocol and key design considerations. BMJ Open Respir Res. 2018 Feb 19;5(1):e000272. doi: 10.1136/bmjresp-2017-000272. eCollection 2018.
PMID: 29531748DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kathleen O Lindell, PhD, RN
Dorothy P. and Richard P. Simmons Center for ILD
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant Professor of Medicine
Study Record Dates
First Submitted
October 6, 2016
First Posted
October 10, 2016
Study Start
March 23, 2017
Primary Completion
June 24, 2020
Study Completion
June 24, 2020
Last Updated
August 7, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share